Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3years for adalimumab-treated patients with early Crohn's disease von Schreiber, S., Reinisch, W., Colombel, J.F., Sandborn, W.J., Hommes, D.W., Robinson, A.M., Huang, B., Lomax, K.G., Pollack, P.F.

Volltext

AB0871 Impact of Familial Mediterranean Fever, MKD/HIDS, and Traps on Patients and Families, Data from Patient Interviews von Hausmann, J., Lomax, K.G., Shapiro, A., Durrant, K.L.

Volltext

THU0233 Impact of Systemic Juvenile Idiopathic Arthritis/still's Disease on Adolescents as Evidenced through Social Media Posting von Modica, R.F., Lomax, K.G., Batzel, P., Cassanas, A., Elder, M.

Volltext

P083 - Steroid-free remission in patients with Crohn's disease who received adalimumab therapy for at least 3 years: long-term results from CHARM von Kamm, M.A., Hanauer, S.B., Panaccione, R., Colombel, J.F., Sandborn, W.J., Lomax, K.G., Pollack, P.F.

Volltext

P148 - Adalimumab maintains long-term remission in patients with moderately to severely active Crohn's disease through 3 years of therapy von Panaccione, R., Colombel, J.F., Sandborn, W.J., Rutgeerts, P., D'Haens, G., Lomax, K.G., Li, J., Pollack, P.F.

Volltext

P205 - Outcome of patients with Crohn's disease and primary sclerosing cholangitis in CHARM and GAIN von Panaccione, R., Rutgeerts, P., Wolf, D., Selby, W., Russel, M., Lomax, K.G., Pollack, P.F.

Volltext

Adalimumab Induces and Maintains Clinical Response and Remission in Patients With Active Crohn’s Disease: Results of the CHARM Trial von Colombel, J., Sandborn, W.J., Rutgeerts, P., Enns, R., Hanauer, S.B., Remo, P., Schreiber, S., Lomax, K.G., Pollack, P.F.

Volltext

P006 ADALIMUMAB MAINTAINS LONG-TERM REMISSION IN CROHN'S DISEASE AFTER INFLIXIMAB FAILURE: 1-YEAR FOLLOW-UP OF GAIN TRIAL von Panaccione, R., Sandborn, W.J., D'Haens, G.R., Enns, R., Wolf, D.C., Lomax, K.G., Pollack, P.F.

Volltext

P137 IMPROVEMENT IN WORK PRODUCTIVITY WITH ADALIMUMAB IN CROHN'S DISEASE PATIENTS WHO FAILED PRIOR INFLIXIMAB: AN ANALYSIS OF THE CHOICE TRIAL von Lichtiger, S., Present, D.H., Persson, B., Wu, E., Kent, J.D., Lomax, K.G., Chao, J., Mulani, P.

Volltext

P019 LONG-TERM FISTULA HEALING AND RESPONSE WITH ADALIMUMAB TREATMENT: 2-YEAR DATA FROM CHARM INCLUDING 1-YEAR OPEN-LABEL EXTENSION von Colombel, J.F., Kamm, M.A., Schwartz, D.A., Sandborn, W.J., Li, J., Lomax, K.G., Pollack, P.F.

Volltext

P002 ADALIMUMAB MAINTAINS LONG-TERM REMISSION IN CROHN'S DISEASE THROUGH 2 YEARS von Panaccione, R., Colombel, J.F., Sandborn, W.J., Rutgeerts, P., D'Haens, G.R., Lomax, K.G., Li, J., Wong, R., Pollack, P.F.

Volltext

An Active Plume Eruption on Europa During Galileo Flyby E26 as Indicated by Energetic Proton Depletions von Huybrighs, H. L. F., Roussos, E., Blöcker, A., Krupp, N., Futaana, Y., Barabash, S., Hadid, L. Z., Holmberg, M. K. G., Lomax, O., Witasse, O.

Volltext